Short description
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Description
Founded in 2013, Frontier Biotechnologies is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, manufacturing, and commercialization of innovative medicines that improve patient health. Their medicines typically address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. Frontier Biotech's first commercial product was approved by the National Medical Product Administration (NMPA), which is the counterpart of the Food and Drug Administration (FDA) in China, in May 2018 through a priority review process and has gained accelerated approval. Two additional drug candidates are currently undergoing multiple clinical trials in Phase I and Phase II in both China and the United States. Frontier Biotech brings together many of the best scholars, scientists, and professionals in R&D, senior management, marketing, international business development, and manufacturing. At Frontier Biotech, their long-standing commitment to excellence is in everything they do throughthe entire development cycle from drug discovery, preclinical research to global clinical development. This approach has enabled Frontier Biotech to emerge in the global market as a competitive player in the field of HIV long-acting treatment and immunotherapy.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Nanjing, Jiangsu, China, Asia
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$7890 - 12340
Sign in for full access
Investors
Nopepepe, Blurry Noaccess, Noway Youcantaccess, Noway Youcantaccess, Noaccessforu
Sign in for full access
Founders
Dong Xie